Bedeutung des C-reaktiven Proteins im Rahmen maligner ...

7. Literaturverzeichnis
58
1. Aden DP, Fogel A, Plotkin S, Damjanow I, Knowles BB. Controlled synthesis of
HbsAg in a different human liver carcinoma-derived cell line. Nature 1979;282:615-616
2. Agrawal A, Shrive AK, Greenhough TJ, Volanakis JE. Topology and structure of the
C1q-binding site on C-reactive protein. J Immunol. 2001;166(6):3998-4004
3. Agrawal A, Cha-Molstad H, Samols D, Kushner I. Overexpressed nuclear factor-κB can
participate in endogenous C-reactive protein induction, and enhances the effects of
C/EBPβ and signal transducer and activator of transcription-3. Immunology
2003;108:539-547
4. Albert MA, Danielson E, Rifai N et al. Effect of statin therapy on C-reactive protein
levels. The Pravastatin Inflammation/CRP Evaluation (PRINCE): a randomized trial
and cohort study. JAMA 2001;286:64-70
5. Atzpodien J, Royston P, Wandert T, Reitz M et al. Metastatic renal carcinoma
comprehensive prognostic system. Br J Cancer 2003;88:348-353
6. Barber MD, Fearon KC, Ross JA. Relationship of serum levels of interleukin-6, soluble
interleukin-6 receptor and tumour necrosis factor receptors to the acute-phase protein
response in advanced pancreatic cancer. Clin Sci 1999;96:83-87
7. Baron JA, Cole BF, Sandler RS, et al. A randomized trial of aspirin to prevent
colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 2003;
348:883-890
8. Baum LL, James KK, Glaviano RR, Gewurz H. Possible role for C-reactive protein in
the human natural killer cell response. J Exp Med 1983;157:301-311
9. Bhakdi S, Torzewski M, Klouche M et al. Complement and atherogenesis : binding of
CRP to degraded, nonoxidized LDL enhances complement activation. Arterioscler
Thromb Vasc Biol 1999;19:2348-2354
10. Bhakdi S, Torzewski M, Paprotka K, Schmitt S, Barsoom H, Suriyaphol P, Han SR,
Lackner KJ, Husmann M. Possible protective role for C-reactive protein in
atherogenesis: complement activation by modified lipoproteins halts before detrimental
terminal sequence. Circulation 2004;109:1870-1876
11. Blood CH, Zetter BR. Tumor interactions with the vasculature: angiogenesis and tumor
metastasis. Biochim Biophys Acta 1990;1032:89-118
12. Boenisch T. Färbemethoden. In: Handbuch II immunchemischer Färbemethoden.
DAKO Corporation, Carpinteria, 3. Aufl., 1997; 22-27
13. Bokemeyer C, Hartmann T. Chemotherapy for renal cell carcinoma. Anticancer Res
1999;19:1541-1543